A personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to a standard treatment
Back to Lifestyle
Lifestyle
October 23, 2026 at 1:45 PM
STAT+: Pharmalittle: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more
STAT News
Excerpt from STAT News.